These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [What is the place of statins in the treatment of diabetes?]. Cariou B Rev Prat; 2016 Mar; 66(3):328-329. PubMed ID: 30512648 [No Abstract] [Full Text] [Related]
12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031 [TBL] [Abstract][Full Text] [Related]
13. [Statins with a perspective of lifelong therapy]. Ertaş FS Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048 [TBL] [Abstract][Full Text] [Related]
14. Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793 [TBL] [Abstract][Full Text] [Related]
15. Coronary artery calcium scoring in patients with statin associated muscle symptoms: Prescribing statins for those most likely to benefit. Orringer CE; Blaha MJ; Stone NJ J Clin Lipidol; 2021; 15(6):782-788. PubMed ID: 34688585 [TBL] [Abstract][Full Text] [Related]
16. Statins: The Good, the Bad, and the Unexpected. Mager DR Home Healthc Now; 2016; 34(7):388-93. PubMed ID: 27348033 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular prevention: lifestyle and statins--competitors or companions? Opie LH; Dalby AJ S Afr Med J; 2014 Mar; 104(3):168-73. PubMed ID: 24897816 [TBL] [Abstract][Full Text] [Related]
18. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS]. Lavie G; Cohen S Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083 [TBL] [Abstract][Full Text] [Related]
19. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related]
20. [Benefits and risks for primary prevention with statins in the elderly]. Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]